<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 17:11:05 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>What Investors Should Look for In Today’s Fed Statement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</guid>
      <description><![CDATA[In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605772>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:04:24 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ING</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</link>
    </item>
    <item>
      <title>Are Discount Brokers Shares Worth Owning?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</guid>
      <description><![CDATA[The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&amp;P gain 15%.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604683>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 01:28:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCHB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</link>
    </item>
    <item>
      <title>Technology Rises And Buying Facebook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</guid>
      <description><![CDATA[Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%.&#160;&#160; Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601987>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:54:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</link>
    </item>
    <item>
      <title>Buffett Gets His Cheque Book Out</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</guid>
      <description><![CDATA[Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601899>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:17:34 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</link>
    </item>
    <item>
      <title>Five Ways To Ride The Commodities Bull</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</guid>
      <description><![CDATA[Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over.
Don’t believe it.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601726>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 15:21:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</link>
    </item>
    <item>
      <title>Donnelley Hunts Revenue in Online Advertising</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3443814</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Aug. 28--Yellow pages publisher R.H. Donnelley, which is restructuring  its business after filing for bankruptcy in May, continues to beef up its  online offerings as it fights for advertising dollars. &lt;/li&gt;&lt;li&gt;This week the Cary-based company, which publishes directories under the  Dex brand name in 28 states, introduced two new features to its online yellow  pages, DexKnows.com. &lt;/li&gt;&lt;li&gt;Donnelley expects to emerge from bankruptcy early next year, and the  moves signal that the company is forging ahead with efforts to boost revenue  in the interim.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3443814>[More...]</a>]]></description>
      <pubDate>Fri, 28 Aug 2009 14:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">T</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3443814</link>
    </item>
    <item>
      <title>Salix Reports Stronger Drug Sales</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3220624</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;May 6--Salix Pharmaceuticals reported a first-quarter loss, but sales of its medicines to treat gastrointestinal ailments rose 30 percent. &lt;/li&gt;&lt;li&gt;The Morrisville company released its latest financial results late Tuesday. &lt;/li&gt;&lt;li&gt;Salix products are used to treat ulcerative colitis, travelers' diarrhea and other diseases.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3220624>[More...]</a>]]></description>
      <pubDate>Wed, 06 May 2009 18:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3220624</link>
    </item>
    <item>
      <title>R.H. Donnelley Reports Weaker Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3112521</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Mar. 12--R.H. Donnelley, the yellow-pages publisher that is struggling to reduce debt as ad sales slump, this morning reported that fourth-quarter revenue fell 7 percent and its losses widened. &lt;/li&gt;&lt;li&gt;The Cary-based company has been cutting costs, including eliminating about 20 percent of its workforce, amid the recession. &lt;/li&gt;&lt;li&gt;The company publishes yellow-pages directories in 28 states and has about 4,000 employees.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3112521>[More...]</a>]]></description>
      <pubDate>Thu, 12 Mar 2009 17:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LAZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHD</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3112521</link>
    </item>
    <item>
      <title>Salix Reports Surge in Q4 Revenues</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3105359</guid>
      <description><![CDATA[Raleigh, North Carolina-based developer and marketer of prescription medical products Salix Pharmaceuticals has reported that its total product revenue was $60.6 million for the fourth quarter of 2008, compared to $39.1 million for the fourth quarter of 2007.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3105359>[More...]</a>]]></description>
      <pubDate>Tue, 10 Mar 2009 20:21:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3105359</link>
    </item>
    <item>
      <title>Pulling Shares Off the Market: Triangle Companies Facing Delisting Can Expect an Arduous Road Back Recession-Battered Companies in the Triangle Face Delisting</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2942719</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jan. 10--At least two Triangle companies are being delisted from major stock exchanges, and several more could follow if their fortunes don't improve -- moves with negative ramifications for companies and investors. &lt;/li&gt;&lt;li&gt;For the companies, meanwhile, being delisted makes it more difficult to raise money by selling stock. &lt;/li&gt;&lt;li&gt;&quot;In general, when a company is faced with a delisting request from the exchange, the company is already in trouble,&quot; said Cory Janssen, co-founder of Investopedia.com, an investment Web site.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2942719>[More...]</a>]]></description>
      <pubDate>Sat, 10 Jan 2009 18:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XRM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2942719</link>
    </item>
    <item>
      <title>BRIEF: Triangle Stocks Took a Beating: Salix Posted Best Results of 25 Companies; 13 Outperformed the S&amp;P 500</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2918355</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jan. 1--It was a dismal year for local stocks. &lt;/li&gt;&lt;li&gt;Of 25 public companies based in the Triangle, only three saw their share prices rise in 2008. &lt;/li&gt;&lt;li&gt;Salix Pharmaceuticals was the Triangle's top performer, logging a 12 percent gain.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2918355>[More...]</a>]]></description>
      <pubDate>Thu, 01 Jan 2009 14:16:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2918355</link>
    </item>
    <item>
      <title>More in Triangle Are Without Jobs: Unemployment Rate Hits 5.4 Percent</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2656334</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 27--The Triangle area's unemployment rate continued its steady climb in August, as the national slump and soaring energy prices hurt hiring prospects for job seekers. &lt;/li&gt;&lt;li&gt;The jobless rate for the region that includes Durham, Johnston, Orange and Wake counties was 5.4 percent in August, according to data released Friday by the N.C. Employment Security Commission and adjusted for seasonal effects by Wachovia in Charlotte. &lt;/li&gt;&lt;li&gt;Still, this region's job market remains stronger than that of the nation, which saw the unemployment rate jump to 6.1 percent in August.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2656334>[More...]</a>]]></description>
      <pubDate>Sat, 27 Sep 2008 09:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PPD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RTP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2656334</link>
    </item>
    <item>
      <title>Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601640</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S.   Patent and Trademark Office has issued U.S. Patent No. &lt;/li&gt;&lt;li&gt;Salix has an exclusive license from Alfa Wassermann, S.p.A., to use,   sell, have sold and import licensed rifaximin products, which the   Company markets in the United States under the trade name XIFAXAN&amp;#174;.   &lt;/li&gt;&lt;li&gt;The U.S. Patent and Trademark Office also issued U.S. Patent No.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601640>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 14:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601640</link>
    </item>
    <item>
      <title>Salix Pharmaceuticals Reports 2Q2009 Results Updates Full Year Guidance</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3405249</guid>
      <description><![CDATA[Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the second quarter ended June 30, 2009.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3405249>[More...]</a>]]></description>
      <pubDate>Mon, 10 Aug 2009 20:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3405249</link>
    </item>
    <item>
      <title>StockPreacher.com Issues Trading Outlook for ViroPharma Inc.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3391017</guid>
      <description><![CDATA[StockPreacher.com announces an investment report featuring biopharmaceutical company ViroPharma Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3391017>[More...]</a>]]></description>
      <pubDate>Tue, 04 Aug 2009 10:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VPHM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3391017</link>
    </item>
    <item>
      <title>Salix Pharmaceuticals to Present at BMO Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3378560</guid>
      <description><![CDATA[Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the BMO Capital Markets Focus on Healthcare Conference in New York, NY on Wednesday, August 5 at 3:30 p.m. ET.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3378560>[More...]</a>]]></description>
      <pubDate>Wed, 29 Jul 2009 10:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3378560</link>
    </item>
    <item>
      <title>Salix Pharmaceuticals Announces 2Q2009 Financial Results Conference Call and Webcast</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3373375</guid>
      <description><![CDATA[Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report second quarter 2009 financial results following the close of the U.S. financial markets on Monday, August 10, 2009.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3373375>[More...]</a>]]></description>
      <pubDate>Mon, 27 Jul 2009 10:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3373375</link>
    </item>
    <item>
      <title>Salix’s Once-Daily APRISO Demonstrates Long-Term Safety in Patients for Maintenance of Remission from Ulcerative Colitis</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3306963</guid>
      <description><![CDATA[Data was announced today that demonstrated Salix Pharmaceuticals’ (NASDAQ:SLXP) APRISO™ (mesalamine) 0.375g extended-release capsules had a favorable safety profile in patients in remission from ulcerative colitis (UC) for up to 24 months. APRISO is approved for use up to six months. The majority of treatment-emergent adverse events were mild or moderate in intensity, and were similar to what was seen during the 6-month phase 3 trials. The study, which is the first to examine the long-term safety profile of APRISO, was presented at the Digestive Disease Week (DDW) annual meeting in Chicago, Illinois.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3306963>[More...]</a>]]></description>
      <pubDate>Tue, 02 Jun 2009 13:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3306963</link>
    </item>
    <item>
      <title>Salix's Once-Daily APRISO Demonstrates Long-Term Safety in Patients for Maintenance of Remission From Ulcerative Colitis</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3306961</guid>
      <description><![CDATA[CHICAGO, IL -- -- 06/02/09 -- Data was announced today that demonstrated Salix Pharmaceuticals' APRISO 0.375g extended-release capsules had a favorable safety profile in patients in remission from ulcerative colitis for up to 24 months. APRISO is approved for use up to six months. The majority of treatment-emergent adverse events were mild or moderate in intensity, and were similar to what was seen during the 6-month phase 3 trials. The study, which is the first to examine the long-term safety profile of APRISO, was presented at the Digestive Disease Week annual meeting in Chicago, Illinois.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3306961>[More...]</a>]]></description>
      <pubDate>Tue, 02 Jun 2009 12:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3306961</link>
    </item>
    <item>
      <title>Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week (DDW)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3306955</guid>
      <description><![CDATA[Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the presentation of new data from its Phase III pivotal clinical trial evaluating the efficacy, safety and tolerability of rifaximin - a non-absorbed (&lt;0.4%), gut selective antibiotic - in adult patients with hepatic encephalopathy (HE). These data, presented during two oral sessions at the annual meeting of Digestive Disease Week (DDW) being held this week in Chicago (May 30-June 4, 2009), demonstrated that rifaximin significantly reduced the risk of HE-related hospitalizations in patients with previous episodes of HE and showed a highly significant reduction in the risk of breakthrough HE during the six month study.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3306955>[More...]</a>]]></description>
      <pubDate>Mon, 01 Jun 2009 10:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3306955</link>
    </item>
    <item>
      <title>Certain Salix Officers and Directors Adopt 10b5-1 Trading Plans for Stock Options That Are Scheduled to Expire During 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3226137</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that certain   officers and directors of the Company have adopted predetermined trading   plans to exercise expiring stock options over time in accordance with   guidelines specified under Rule 10b5-1 of the Securities Exchange Act of   1934, as amended, and with Salix' policies regarding stock transactions   and ownership. &lt;/li&gt;&lt;li&gt;The Salix officers and directors who have entered into Rule 10b5-1 stock   trading plans include:&lt;/li&gt;&lt;li&gt;Thomas W. D'Alonzo - Director;&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3226137>[More...]</a>]]></description>
      <pubDate>Mon, 11 May 2009 14:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3226137</link>
    </item>
    <item>
      <title>Salix Pharmaceuticals Reports 1Q2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3306886</guid>
      <description><![CDATA[Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the first quarter ended March 31, 2009.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3306886>[More...]</a>]]></description>
      <pubDate>Tue, 05 May 2009 20:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3306886</link>
    </item>
    <item>
      <title>Form  4          DERBYSHIRE ADAM C         For: Nov 04 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614075</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614075>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 14:23:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614075</link>
    </item>
    <item>
      <title>Form  4          SALIX PHARMACEUTICALS     For: Oct 21  Filed by: DERBYSHIRE ADAM C (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3576294</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3576294>[More...]</a>]]></description>
      <pubDate>Fri, 23 Oct 2009 20:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3576294</link>
    </item>
    <item>
      <title>Form  4          DERBYSHIRE ADAM C         For: Oct 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3552114</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3552114>[More...]</a>]]></description>
      <pubDate>Wed, 14 Oct 2009 21:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3552114</link>
    </item>
    <item>
      <title>Form  4          DERBYSHIRE ADAM C         For: Oct 07 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539699</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539699>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 22:27:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539699</link>
    </item>
    <item>
      <title>Form  4          DERBYSHIRE ADAM C         For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3521131</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3521131>[More...]</a>]]></description>
      <pubDate>Thu, 01 Oct 2009 21:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3521131</link>
    </item>
    <item>
      <title>Form  4          DERBYSHIRE ADAM C         For: Sep 23 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3504677</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3504677>[More...]</a>]]></description>
      <pubDate>Thu, 24 Sep 2009 22:04:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3504677</link>
    </item>
    <item>
      <title>Form  4          DERBYSHIRE ADAM C         For: Sep 16 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3485967</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3485967>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 22:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3485967</link>
    </item>
    <item>
      <title>Form  4/A        LOGAN CAROLYN J           For: Sep 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3483141</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3483141>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 00:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3483141</link>
    </item>
    <item>
      <title>Form  4          LOGAN CAROLYN J           For: Sep 14 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3481079</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3481079>[More...]</a>]]></description>
      <pubDate>Tue, 15 Sep 2009 16:24:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3481079</link>
    </item>
    <item>
      <title>Form  4          DEERFIELD INTERNATIONAL   For: Sep 08 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3472547</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3472547>[More...]</a>]]></description>
      <pubDate>Fri, 11 Sep 2009 00:19:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3472547</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=RHD,SLXP," rel="self" type="application/rss+xml" />
  </channel>
</rss>